BlackRock Fund Advisors - TRACON PHARMACEUTICALS INC ownership

Quarter-by-quarter ownership
BlackRock Fund Advisors ownership history of TRACON PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2016$103,000
-23.7%
20,990
+3.6%
0.00%
Q3 2016$135,000
+51.7%
20,258
-0.2%
0.00%
Q2 2016$89,000
+23.6%
20,306
+95.8%
0.00%
Q1 2016$72,000
-30.1%
10,369
-6.9%
0.00%
Q4 2015$103,00011,1350.00%
Other shareholders
TRACON PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
683 Capital Management, LLC 995,000$3,134,0000.33%
NEA Management Company, LLC 2,759,217$8,692,0000.30%
Eventide Asset Management 900,000$2,835,0000.16%
QVT Financial LP 308,227$916,0000.03%
Candriam S.C.A. 143,000$450,0000.01%
Virtu Financial LLC 23,684$75,0000.00%
TWO SIGMA SECURITIES, LLC 13,352$42,0000.00%
BLUESTEIN R H & CO LLC 16,000$50,0000.00%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 54,135$171,0000.00%
Alyeska Investment Group, L.P. 97,676$308,0000.00%
View complete list of TRACON PHARMACEUTICALS INC shareholders